FDA Chemist, US Close To Deal In Insider Trading Case

Law360, New York (September 19, 2011, 9:53 PM EDT) -- Prosecutors who charged a U.S. Food and Drug Administration chemist with insider trading based on information about companies with pending drug applications said Monday that a deal was imminent, but requested more time to finalize the agreement.

This is the fourth time since the arrest of chemist Cheng Yi Liang and his son Andrew Liang that both sides sought to delay the case in order to iron out a settlement. Prosecutors and Cheng Yi Liang asked the Maryland federal court for an extra week.

Cheng Yi...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.